AriBioLab Co.,Ltd. (KOSDAQ:261780)

AriBioLab Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	6,938	9,775	10,092	5,906	2,386	3,955
Short-Term Investments	5,490	13,490	22,550	32,990	55,377	47,500
Trading Asset Securities	3,213	406.79	7,465	-	-	10,095
Cash & Short-Term Investments	15,641	23,672	40,107	38,896	57,763	61,550
Cash Growth	-53.85%	-40.98%	3.11%	-32.66%	-6.15%	147.92%
Accounts Receivable	-0	-0	-0	0	-0	-0
Other Receivables	345.21	468.61	399.87	453.87	607.81	266.9
Receivables	345.21	468.61	399.87	453.87	607.8	266.9
Prepaid Expenses	85.99	77.23	106.63	94.23	117.1	12.94
Other Current Assets	2,482	2,661	3,977	3,042	429	17.07
Total Current Assets	18,554	26,879	44,590	42,486	58,917	61,847
Property, Plant & Equipment	702.86	842.79	1,120	1,644	1,543	1,032
Long-Term Investments	1,442	1,612	1,069	674.6	440	2,300
Other Intangible Assets	238.01	229.85	174.67	43.58	39.91	21.77
Long-Term Accounts Receivable	0	0	0	0	0	0
Other Long-Term Assets	209.28	217.88	294.39	270.9	129.08	112.5
Total Assets	21,146	29,782	47,248	45,119	61,069	65,313

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accrued Expenses	97.29	105.37	129.31	146.74	77.43	60.77
Short-Term Debt	6,189	8,841	4,950	-	23,240	20,717
Current Portion of Leases	-	-	8.35	162.92	381.21	112.8
Other Current Liabilities	3,391	7,239	4,526	500.53	3,090	3,816
Total Current Liabilities	9,677	16,185	9,613	810.18	26,789	24,706
Long-Term Debt	-	-	4,627	3,975	-	-
Long-Term Leases	-	-	3.81	188.65	16.53	16.14
Pension & Post-Retirement Benefits	1,472	1,625	1,620	1,203	882.35	737.9
Other Long-Term Liabilities	106.83	112.64	3,662	3,525	15.09	237.52
Total Liabilities	11,255	17,923	19,526	9,702	27,703	25,698

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	13,456	13,433	13,412	13,366	13,215	13,215
Additional Paid-In Capital	82,565	79,870	79,687	76,782	72,576	72,576
Retained Earnings	-86,475	-81,939	-65,920	-55,457	-53,615	-46,921
Comprehensive Income & Other	344.26	495.63	542.97	725.68	1,190	745.6
Shareholders' Equity	9,891	11,859	27,722	35,417	33,366	39,615
Total Liabilities & Equity	21,146	29,782	47,248	45,119	61,069	65,313

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	6,189	8,841	9,589	4,327	23,638	20,846
Net Cash (Debt)	9,452	14,831	30,518	34,569	34,125	40,704
Net Cash Growth	-59.36%	-51.40%	-11.72%	1.30%	-16.16%	579.94%
Net Cash Per Share	351.51	552.25	1137.84	1304.13	1290.78	1745.71
Filing Date Shares Outstanding	26.89	26.87	26.82	26.73	26.43	26.43
Total Common Shares Outstanding	26.89	26.87	26.82	26.73	26.43	26.43
Working Capital	8,877	10,694	34,977	41,676	32,128	37,141
Book Value Per Share	367.79	441.43	1033.46	1324.89	1262.45	1498.91
Tangible Book Value	9,653	11,629	27,548	35,373	33,326	39,593
Tangible Book Value Per Share	358.94	432.87	1026.95	1323.26	1260.94	1498.09
Land	95.09	95.09	95.09	95.09	95.09	95.09
Buildings	402.68	402.68	402.68	402.68	402.68	402.68
Machinery	2,225	2,205	2,086	1,933	1,622	1,079

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 2, 2026

Data Sources Report a data error